Pearl T. L. Siew
Senior Vice President and Head, Intellectual Property at Eagle Pharmaceuticals, Inc. (Woodcliff Lake, NJ)
PEARL T.L. SIEW is Senior Vice President and Head, Intellectual Property at Eagle Pharmaceuticals, Inc. Pearl innovates and implements cutting-edge IP strategies for go-to-market approaches, litigations, and settlements to maximize product value. She has extensive patent litigation experience representing both brand and generic companies primarily relating to pharmaceutical litigation under the Hatch-Waxman Act. Pearl began her practice as outside counsel, focusing on litigating Hatch-Waxman patent and related Administrative Procedure Act cases. She later became in-house counsel, with roles including Vice President & Head, Intellectual Property, U.S., at Sandoz, and her current role as Senior Vice President & Head of Intellectual Property at Eagle Pharmaceuticals, Inc. Pearl has set the IP and Hatch-Waxman strategies from product idea inception, through development and launch. As a cross-functional leader, Pearl works hand in hand with commercial, regulatory, and technical partners to optimize commercial value and risk.